Garweg, Justus G. http://orcid.org/0000-0003-3973-5082
Štefanickova, Jana
Hoyng, Carel
Niesen, Tobias
Schmelter, Thomas
Leal, Sergio
Sivaprasad, Sobha
,
Schmidt-Erfurth, Ursula
Wedrich, Andreas
Ali, Fareed
Chow, David
Dickinson, John
Giunta, Michel
Hasan, Jesia
Dusova, Jaroslava
Hamouz, Jan
Kodjikian, Laurent
Souied, Eric
Dahlke, Claudia
Emmerich, Karl-Heinz
Feltgen, Nicolas
Holz, Frank
Koch, Frank
Sandner, Dirk
Sekundo, Walter
Kerenyi, Agnes
Papp, Andras
Seres, Andras
Vajas, Attila
Varsanyi, Balazs
Bandello, Francesco
Boscia, Francesco
Eandi, Chiara
Midena, Edoardo
Nicolo, Massimo
Peiretti, Enrico
Ricci, Federico
Viola, Francesco
Virgili, Gianni
Balciuniene, Vilma-Jurate
Cimbalas, Andrius
Graczynska, Ewa
Grzybowski, Andrzej
Kaluzny, Jakub
Michalewska, Zofia
Raczynska, Dorota
Rekas, Marek
Romanowska-Dixon, Bozena
Teper, Slawomir
Zarnowski, Tomasz
Amaro, Miguel
Sousa, João Castro
Falcão, Manuel
Figueira, João Pereira
Vaz-Pereira, Sara
Alexik, Mikulas
Gajdosova, Monika
Pavlovicova, Gabriela
Štefanickova, Jana
Struharova, Katarina
Adan, Alfredo
Barquet, Lluis Arias
Bures, Anniken
Valenciano, Carlos Cava
Cervera, Enrique
Sararols, Laura
Garweg, Justus
Petropoulos, Ioannis
Lotery, Andrew
McKibbin, Martin
Sivaprasad, Sobha
Varma, Deepali
Clinical trials referenced in this document:
Documents that mention this clinical trial
Dosing Regimens of Intravitreal Aflibercept for Diabetic Macular Edema Beyond the First Year: VIOLET, a Prospective Randomized Trial
https://doi.org/10.1007/s12325-022-02119-z
Funding for this research was provided by:
Bayer AG
Article History
Received: 21 January 2022
Accepted: 7 March 2022
First Online: 12 April 2022